Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Business Growth Plans: Diversifying Product Lines and Strengthening Technology Integration|Dhiraj Patel,Managing Director,Vikram Thermo (India) Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dhiraj Patel,Chaiman and Managing Director
Recent Videos
00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.
Suggestions
00:10:00
Koffee Chats with Klaas: Concentration vs. Diversification in Retirement Planning
00:10:00
A Financial Analyst at SilverStone Group, Inc. holding a Chemistry bachelor's degree and an MBA from Creighton University.
00:10:00
Severn Trent's Financial Performance and Social Purpose Initiatives Set the Stage for a Bright Future Ahead | Liv Garfield, Managing Director ,Severn Trent PLC.
00:10:00
Air Canada CEO Calin Rovinescu on Rebranding, Market Positioning, and the Future of Air Travel | Calin Rovinescu, CEO, Air Canada.
00:10:00
Angi CEO Oisin Hanrahan on Quarterly Earnings and Market Trends | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Randy Kurtz’s Data Driven Advisor Program: Transforming Financial Planning | Randy Kurtz, President , Upper Left Wealth Management.
00:10:00
Dan Flexman's Inspirational Story of Overcoming Adversity
00:10:00
Reid AI', deepfake concerns and state of AI arms race|Reid Hoffman,investor,Greylock
00:10:00
Joe Ucuzoglu on Deloitte's Role in Shaping Business, Society, and Technology Trends | Joe Ucuzoglu, CEO , Deloitte.
00:10:00
Navigating Waste Management: Insights from Waste Management, Inc. CEO
00:00:00
NetScientific PLC actively driving its investee companies forward - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:10:00
Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.